Bibliographic record
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, Jódar E, Kandler K, Rigas G, Wadden TA, Wharton S. Nature Medicine 2022
§1Bibliographic record
§1.1Record
- Authors
- Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, Jódar E, Kandler K, Rigas G, Wadden TA, Wharton S
- Title
- Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
- Source
- Nature Medicine
- Year
- 2022
- Volume, issue, pages
- 28(10):2083–2091
- Digital object identifier
- 10.1038/s41591-022-02026-4
- PubMed identifier
- 36216945
- Record type
- Journal article
- Institute identifier
- CEI-BR-031
§1.2Institute documents citing this record
Table 1. Documents in the Institute set that cite this record.
§1.3Subject tags
semaglutide obesity long-term STEP
Compound Evidence Institute · CEI-BR-031 · https://compoundevidence.com/bibliography/garvey2022/ · retrieved 30 July 2026